Influence of psychotropic drugs and beta-diethylaminoethyl-diphenylpropylacetate (SKF 525-A) on mescaline-induced behavior and on tissue levels of mescaline in mice.
D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology; D014150:Antipsychotic Agents / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects*; D001921:Brain / Q000378:metabolism; D002746:Chlorpromazine / Q000378:metabolism; D003975:Diazepam / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D005123:Eye / Q000378:metabolism; D005260:Female; D008099:Liver / Q000378:metabolism; D008297:Male; D008635:Mescaline / Q000378:metabolism* / Q000494:pharmacology; D008653:Mesoridazine / Q000378:metabolism; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D010648:Phenylacetates / Q000378:metabolism; D011335:Proadifen / Q000494:pharmacology*; D011619:Psychotropic Drugs / Q000008:administration & dosage / Q000494:pharmacology*; D013045:Species Specificity
D014151:Anti-Anxiety Agents; D014150:Antipsychotic Agents; D010648:Phenylacetates; D011619:Psychotropic Drugs; D008653:Mesoridazine; D011335:Proadifen; D003975:Diazepam; D008635:Mescaline; D002746:Chlorpromazine